Rybelsus 7mg (Semaglutide Tablet) 7mg

Rybelsus 7mg is a prescription tablet containing semaglutide, a GLP-1 receptor agonist used to support blood sugar management in adults with type 2 diabetes. This 7mg strength tablet is taken orally and comes in a 30-tablet pack. It is designed for ambient temperature storage and is manufactured by Novo Nordisk.

Strength

7mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rybelsus 7mg (semaglutide) is used alongside diet and exercise to improve blood sugar levels in adults with type 2 diabetes. It is not a substitute for insulin and is typically prescribed when other oral medications have not provided adequate control. People often ask what is Rybelsus 7mg used for, and it is primarily indicated for type 2 diabetes management.

Side Effects

Rybelsus 7mg helps regulate blood sugar by stimulating insulin release and reducing glucagon secretion when blood sugar is high. Users may notice improved glucose levels over time with consistent use. Common effects include mild gastrointestinal discomfort, especially when starting treatment.

Precautions & Warnings

Store Rybelsus 7mg tablets at room temperature, away from moisture and heat. Keep the medication in its original packaging until ready to use. Do not use if the tablets appear damaged or discolored. Always follow your healthcare provider’s instructions for safe handling and disposal.

Avoid Interactions

Rybelsus 7mg may interact with other medications that affect blood sugar, such as insulin or sulfonylureas, potentially increasing the risk of hypoglycemia. Alcohol and certain antibiotics may also influence its effects. Consult your doctor before combining it with other drugs, especially if you take oral contraceptives or digoxin.

Frequently Asked Questions

Rybelsus 7mg tablets should be taken on an empty stomach with no more than 4 ounces of plain water, at least 30 minutes before your first meal of the day.

Common side effects include nausea, stomach pain, diarrhea, or constipation, especially when starting the medication.

Individual responses vary, but some users may notice improved blood sugar levels within a few weeks of consistent use.

No, Rybelsus 7mg is not a substitute for insulin and should not be used in people with type 1 diabetes or diabetic ketoacidosis.

No, Rybelsus 7mg is a prescription medication and cannot be legally purchased without a valid prescription from a licensed healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.